Bicara Therapeutics Inc. (BCAX) ROA
- 2026-06-30: ROA -36.19%.
- 2026-03-31: ROA -28.42%.
- 2025-12-31: ROA -32.01%.
- 2025-09-30: ROA -28.61%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -36.19% |
| 2026-03-31 | -28.42% |
| 2025-12-31 | -32.01% |
| 2025-09-30 | -28.61% |
| 2025-06-30 | -22.64% |
| 2025-03-31 | -19.31% |
| 2024-12-31 | -13.33% |
| 2024-09-30 | -11.35% |
| 2023-12-31 | -22.22% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -32.01% |
| 2024-12-31 | -13.33% |
| 2023-12-31 | -22.22% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |